BREMBILLA, GIORGIO
 Distribuzione geografica
Continente #
AS - Asia 950
NA - Nord America 844
EU - Europa 763
SA - Sud America 157
AF - Africa 24
OC - Oceania 10
Totale 2.748
Nazione #
US - Stati Uniti d'America 805
SG - Singapore 395
IT - Italia 388
CN - Cina 305
BR - Brasile 131
HK - Hong Kong 124
SE - Svezia 72
DE - Germania 56
VN - Vietnam 44
GB - Regno Unito 43
FI - Finlandia 39
NL - Olanda 38
RU - Federazione Russa 32
CA - Canada 26
FR - Francia 22
IN - India 20
ES - Italia 16
PL - Polonia 13
TR - Turchia 12
IE - Irlanda 11
JP - Giappone 11
MX - Messico 10
AT - Austria 9
AR - Argentina 8
BD - Bangladesh 8
LT - Lituania 8
ZA - Sudafrica 8
AU - Australia 6
EC - Ecuador 6
EG - Egitto 6
AE - Emirati Arabi Uniti 4
CO - Colombia 4
DZ - Algeria 4
IL - Israele 4
IQ - Iraq 4
NZ - Nuova Zelanda 4
PY - Paraguay 4
UA - Ucraina 4
BE - Belgio 3
PK - Pakistan 3
TW - Taiwan 3
AZ - Azerbaigian 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
ID - Indonesia 2
KE - Kenya 2
KR - Corea 2
MY - Malesia 2
VE - Venezuela 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
IR - Iran 1
KH - Cambogia 1
LV - Lettonia 1
MA - Marocco 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
ZW - Zimbabwe 1
Totale 2.748
Città #
Singapore 238
Dallas 165
Ashburn 124
Hong Kong 123
Milan 95
Shanghai 65
New York 64
Beijing 57
Los Angeles 45
Hefei 40
Rome 32
Naples 21
Turku 21
Boardman 20
Munich 19
São Paulo 19
Ho Chi Minh City 17
Lawrence 16
Moscow 16
Princeton 16
Santa Clara 16
Brooklyn 15
Bari 14
Hanoi 14
Montreal 13
Dublin 11
Helsinki 11
Turin 11
Brescia 10
Denver 10
Poplar 10
Suzhou 10
Valencia 10
Warsaw 10
Washington 10
Frankfurt am Main 9
Tokyo 9
Atlanta 8
Chennai 8
Orem 8
Stockholm 8
Toronto 8
Bologna 7
Manchester 7
Nuremberg 7
Padova 7
Palermo 7
The Dalles 7
Ankara 6
Columbus 6
Council Bluffs 6
Damietta 6
Falkenstein 6
Amsterdam 5
Belo Horizonte 5
Chicago 5
Mexico City 5
Phoenix 5
Seattle 5
Auckland 4
Bexley 4
Bolzano 4
Cesano Boscone 4
Charleston 4
Fortaleza 4
Genoa 4
Guangzhou 4
Jiaxing 4
Lappeenranta 4
London 4
New Delhi 4
Secaucus 4
Sydney 4
Tianjin 4
Trieste 4
Asunción 3
Bergamo 3
Boston 3
Brussels 3
Changsha 3
Contagem 3
Florence 3
Guayaquil 3
Johannesburg 3
Milwaukee 3
Mumbai 3
Paderborn 3
Paderno Dugnano 3
Querétaro 3
Romagnano Sesia 3
Rotterdam 3
Silvi 3
Southwark 3
Treviglio 3
Vienna 3
Vimodrone 3
Watford 3
Acerra 2
Afragola 2
Ajman 2
Totale 1.684
Nome #
Simplification of prostate MRI protocol and development of a novel MRI technique for prostate cancer detection and characterization 331
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 126
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 109
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 106
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 99
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 98
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images 89
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 89
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 80
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 78
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 75
Diagnostic Accuracy of Abbreviated Bi-Parametric MRI (a-bpMRI) for Prostate Cancer Detection and Screening: A Multi-Reader Study 74
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 71
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 71
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 70
There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies 66
Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1 64
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer 63
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis 62
Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization 60
Advanced Imaging Analysis in Prostate MRI: Building a Radiomic Signature to Predict Tumor Aggressiveness 58
Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer 57
Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer 56
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 55
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 54
The Challenge of External Generalisability: Insights from the Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference 52
Embolization of superior rectal arteries for transfusion dependent haemorrhoidal bleeding in severely cardiopathic patients: a new field of application of the “emborrhoid” technique 51
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 48
Beyond diagnosis: is there a role for radiomics in prostate cancer management? 47
US/TOF-PET endorectal probe compatible with MR, for diagnosis and staging of the prostate cancer 47
Quantification of Prostate Cancer Metabolism Using 3D Multiecho bSSFP and Hyperpolarized [1-13 C] Pyruvate: Metabolism Differs Between Tumors of the Same Gleason Grade 43
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 41
MpMRI of the prostate: is there a role for semi-quantitative analysis of DCE-MRI and late gadolinium enhancement in the characterisation of prostate cancer? 38
Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection 37
ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI 33
Tackling Interobserver Variability in Multiparametric Magnetic Resonance Imaging (MRI): Is MRI Even Better than We Think for Prostate Cancer Diagnosis? 32
Not All Multiparametric Magnetic Resonance Imaging–targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer 31
Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging 30
Therapeutic EUS: Biliary drainage - The interventional radiologist's perspective 30
Head-to-head comparison of nephrometry scores for partial nephrectomy: implications for clinical guidelines 19
Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI 16
A machine learning-based analysis for the definition of an optimal renal biopsy for kidney cancer 14
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional series 13
AI-Assisted vs Unassisted Identification of Prostate Cancer in Magnetic Resonance Images 10
Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis: The PRIME Diagnostic Clinical Trial 10
Vesical Imaging-Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancer 8
Utility of MRI perilesional biopsy in prostate cancer: impact of the Prostate Imaging-Reporting and Data System and biopsy history 8
The added value of artificial intelligence using Quantib Prostate for the detection of prostate cancer at multiparametric magnetic resonance imaging 8
Global Variation in Magnetic Resonance Imaging Quality of the Prostate 7
Dissemination of endometrial cancer MRI staging guidelines among young radiologists: an ESUR Junior Network survey 6
Extraprostatic incidental findings on prostate mpMRI: A pictorial review from the ESUR junior network 6
AI-powered prostate cancer detection: a multi-centre, multi-scanner validation study 5
Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study 5
Is MRI ready to replace biopsy during active surveillance? 4
Diagnostic Accuracy of Fully Hybrid PET/MRI with [ 68 Ga]Ga-PSMA-11 and [ 68 Ga]Ga-RM2 in Detecting Primary Prostate Cancer: A Phase 2 Trial with Histology as Gold Standard 4
Diagnostic accuracy of abbreviated biparametric MRI for prostate cancer screening: a prospective feasibility study (ReIMAGINE study) 4
PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI 4
Prevalence of MRI lesions in men responding to a GP-led invitation for a prostate health check: A prospective cohort study 4
Evaluating Biparametric Versus Multiparametric Magnetic Resonance Imaging for Diagnosing Clinically Significant Prostate Cancer: An International, Paired, Noninferiority, Confirmatory Observer Study 3
Less Is More: Enhancing Prostate MRI Without Intravenous Contrast 3
The ReIMAGINE prostate cancer risk study protocol: A prospective cohort study in men with a suspicion of prostate cancer who are referred onto an MRI-based diagnostic pathway with donation of tissue, blood and urine for biomarker analyses 3
ESR Essentials: using the right scoring system in prostate MRI—practice recommendations by ESUR 3
Improving image quality in prostate MRI: the time is now 2
Totale 2.890
Categoria #
all - tutte 15.966
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.966


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 2 0 0 0 0 1 0
2021/202212 0 4 1 2 0 1 3 1 0 0 0 0
2022/2023183 40 22 13 10 3 13 10 13 4 5 32 18
2023/2024363 6 22 36 33 28 76 10 30 5 40 31 46
2024/2025911 68 29 35 43 72 89 140 99 117 48 86 85
2025/20261.400 209 177 194 318 387 115 0 0 0 0 0 0
Totale 2.890